Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 6 Liver Neoplasms 5 Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Endometrial Neoplasms 1 Deglutition Disorders 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Anal Canal Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 9 Radiotherapy 7 Cisplatin 7 Radiotherapy, Intensity-Modulated 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Nivolumab 3 Capecitabine 3 dehydroftorafur 2 Taxes 2 Paclitaxel 2 Cetuximab 2 Carboplatin 2 Biopsy 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 VGX-3100 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Brachytherapy × Gastrointestinal × Clear all

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡